{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:26:42Z","timestamp":1756384002001},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T00:00:00Z","timestamp":1268784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s13181-010-0019-4","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T18:59:01Z","timestamp":1268765941000},"page":"420-423","source":"Crossref","is-referenced-by-count":16,"title":["Corticosteroid Therapy in a Case of Severe Cholestasic Hepatitis Associated with Amoxicillin\u2013Clavulanate"],"prefix":"10.1007","volume":"6","author":[{"given":"Jos\u00e9-Ignacio","family":"Herrero-Herrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Garc\u00eda-Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.21324","volume":"44","author":"MI Lucena","year":"2006","unstructured":"Lucena MI, Andrade RJ, Fern\u00e1ndez MC, Pachkoria K, Pel\u00e1ez G, Dur\u00e1n JA et al (2006) Determinants of the clinical expression of amoxicillin\u2013clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 44:850\u2013856","journal-title":"Hepatology"},{"key":"19_CR2","first-page":"4.1","volume":"23","author":"Agencia Espa\u00f1ola del Medicamento","year":"2006","unstructured":"Agencia Espa\u00f1ola del Medicamento (2006) Uso de la asociaci\u00f3n amoxicilina\u2013clavul\u00e1nico y riesgo de hepatotoxicidad. Bolet\u00edn de la Tarjeta Amarilla 23:4.1","journal-title":"Bolet\u00edn de la Tarjeta Amarilla"},{"key":"19_CR3","doi-asserted-by":"crossref","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, Pel\u00e1ez G, Pachkoria K, Garc\u00eda-Ruiz E, et al (on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease) (2005) Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512\u2013521","DOI":"10.1016\/j.gastro.2005.05.006"},{"key":"19_CR4","first-page":"139","volume":"6","author":"U Gresser","year":"2001","unstructured":"Gresser U (2001) Amoxicillin\u2013clavulanic acid therapy may be associated with severe side effects\u2014review of the literature. Eur J Med Res 6:139\u2013149","journal-title":"Eur J Med Res"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.14.6774","volume":"14","author":"K Tajiri","year":"2008","unstructured":"Tajiri K, Shimizu Y (2008) Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 14:6774\u20136785","journal-title":"World J Gastroenterol"},{"key":"19_CR6","first-page":"551","volume":"19","author":"J Ferrando","year":"2002","unstructured":"Ferrando J, Sanz P, Sevilla G, Figueras P, Mart\u00edn I (2002) Insuficiencia hep\u00e1tica secundaria a hepatitis por amoxicilina-\u00e1cido clavul\u00e1nico. Tratamiento con corticoides. Med Interna 19:551\u2013552","journal-title":"Med Interna"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1345\/aph.1G345","volume":"40","author":"A Giannattasio","year":"2006","unstructured":"Giannattasio A, D'Ambrosi M, Volpicelli M, Iorio R (2006) Steroid therapy for a case of severe drug-induced cholestasis. Ann Pharmacother 40:1196\u20131199","journal-title":"Ann Pharmacother"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00042737-200012030-00017","volume":"12","author":"P Katsinelos","year":"2000","unstructured":"Katsinelos P, Vasiliadis T, Xiarchos P, Patakiouta F, Christodoulou K, Pilpilidis I, Eugenidis N (2000) Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin\u2013clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases. Eur J Gastroenterol Hepatol 12:365\u2013368","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323\u20131330","journal-title":"J Clin Epidemiol"},{"key":"19_CR10","first-page":"1495","volume":"132","author":"JWG Broek Van den","year":"1988","unstructured":"Van den Broek JWG, Buennemeyer BLM, Stricker BHCh (1988) Cholestatische hepatitis door de combinatie amoxicilline en clavulaanzuur (Augmentin). Ned Tijdschr Geneeskd 132:1495\u20131497","journal-title":"Ned Tijdschr Geneeskd"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.meg.0000250581.77865.68","volume":"19","author":"SH Hussaini","year":"2007","unstructured":"Hussaini SH, O'Brien CS, Despott EJ, Dalton HR (2007) Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 19:15\u201320","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","volume":"33","author":"D Larrey","year":"1992","unstructured":"Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel M, Benhamou JP (1992) Hepatitis associated with amoxicillin\u2013clavulanic acid combination: report of 15 cases. Gut 33:368\u2013371","journal-title":"Gut"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.47.5.717","volume":"47","author":"J O'Donohue","year":"2000","unstructured":"O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR (2000) Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47:717\u2013720","journal-title":"Gut"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","volume":"58","author":"FJ Abajo De","year":"2004","unstructured":"De Abajo FJ, Montero D, Madruga M, Garc\u00eda LA (2004) Acute and clinically relevant drug-induced liver injury: a population based case\u2013control study. Br J Clin Pharmacol 58:71\u201380","journal-title":"Br J Clin Pharmacol"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.5694\/j.1326-5377.1995.tb126049.x","volume":"162","author":"JA Thomson","year":"1995","unstructured":"Thomson JA, Fairley CK, Ugoni AM, Forbes AB, Purcell PM, Desmond PV et al (1995) Risk factors for the development of amoxcycillin\u2013clavulanic acid associated jaundice. Med J Aust 162:638\u2013640","journal-title":"Med J Aust"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"W Lee","year":"2003","unstructured":"Lee W (2003) Drug-induced hepatotoxicity. N Eng J Med 349:474\u2013485","journal-title":"N Eng J Med"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gtc.2008.02.002","volume":"37","author":"BA Luxon","year":"2008","unstructured":"Luxon BA (2008) Diagnosis and treatment of autoimmune hepatitis. Gastroenterol Clin North Am 37:461\u2013478","journal-title":"Gastroenterol Clin North Am"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-010-0019-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-010-0019-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-010-0019-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T17:23:09Z","timestamp":1559582589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-010-0019-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s13181-010-0019-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}